Influence of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis
Incidence
The sufferers’ imply age was 66.4 years, and 76.5% had been male. The median follow-up interval was 36.8 months (interquartile vary 21.8–57.6 months). Throughout follow-up, 119 (26.7%) sufferers skilled RD greater than as soon as (vary 1–4 episodes), and 78 (65.5% of these with RD) skilled particular AE (vary 1–3 episodes) (Desk S1 and Fig. S2). The 1-, 2-, and 3-year cumulative incidence of the primary AE had been 6.7%, 12.6%, and 16.6%, respectively (Fig. 1) and incidence price was 57.4/1000 person-years throughout follow-up interval. The proportion of idiopathic and triggered AE was 82.1% (n = 64) and 17.9% (n = 14), respectively. Amongst 14 triggered AE, 12 had been triggered by an infection, adopted by drug toxicity and post-operative situation (n = 1 every) (Desk S1). AE tended to happen extra ceaselessly in winter and spring (n = 44, 56.4%) in comparison with the opposite seasons (n = 34, 43.6%) (Fig. S3).

Comparability of incidence of AE of IPF based on 2007 and 2016 definition of AE. AE acute exacerbation, IPF idiopathic pulmonary fibrosis.
Danger components
Sufferers within the RD group had larger CRP ranges, decrease lung operate (FVC, DLco, and TLC), shorter distance and decrease oxygen saturation (SpO2; resting and the bottom) throughout the 6MWT and extra frequent DP than the no-RD group (Desk 1). Within the AE group, sufferers had been of older age, had decrease lung operate, shorter distance, and decrease SpO2 (resting and the bottom) throughout the 6MWT, and extra frequent DP than these within the no-RD group.
Within the unadjusted Cox regression evaluation, older age, decrease lung operate, shorter distance, and decrease SpO2 (resting and the bottom) throughout the 6MWT, and DP had been considerably related to prevalence of AE in sufferers with IPF (Desk 2). Within the multivariable evaluation, older age, decrease DLco, and DP had been independently related to AE-IPF.
Survival throughout hospitalization
Throughout hospitalization, sufferers with AE (n = 78) confirmed a better in-hospital mortality price (29.5% vs. 9.8%, p = 0.015) than these with no-AE RD (n = 41). The in-hospital mortality between idiopathic and triggered AE teams didn’t differ (32.8% vs. 14.3%, p = 0.211). Among the many sufferers with AE, the non-survivors, on the time of hospitalization, had shorter period of dyspnea earlier than hospitalization, extra frequent fever, larger CRP ranges, and decrease arterial oxygen partial strain/fractional impressed oxygen (P/F) ratio than the survivors (Desk S2). For therapy of AE, all 78 sufferers obtained empirical antibiotics, 57 (73.1%) obtained intravenous corticosteroid remedy (9 with steroid pulse [500 mg/d or more of methylprednisolone], 38 with excessive dose steroid [0.5 mg/kg/d or more of methylprednisolone]) and 10 with low dose steroid [less than 0.5 mg/kg/d of methylprednisolone]) for therapy of AE. As well as, 16 sufferers (20.5%) had been handled with immunosuppressive brokers (10 with cyclosporine, 5 with azathioprine and 1 with mycophenolate mofetil). There was no vital variations of therapy between the survivors and non-survivors throughout hospitalization in sufferers with AE (Desk S3).
Within the unadjusted logistic evaluation, shorter period of dyspnea, fever, larger CRP ranges, and decrease P/F ratio, and extra frequent use of steroid earlier than AE had been considerably related to the in-hospital mortality in IPF sufferers with AE (Desk S4). Within the multivariable evaluation, decrease P/F ratio was the one unbiased prognostic issue towards in-hospital mortality in IPF sufferers with AE. Survival charges after hospitalization between idiopathic and triggered circumstances (median survival interval, 4.1 months vs. 5.5 months, p = 0.656; Fig. S4) didn’t differ.
Influence on total survival
Throughout follow-up, 207 (46.5% of complete topics) sufferers with IPF died. There have been vital variations in total survival from the prognosis of IPF between sufferers skilled AE (median survival interval: 23.5 months) and others (vs. 42.4 months [no-AE RD], p = 0.017; vs. not reached [no-RD], p < 0.001; Fig. 2A).

(A) Comparability of survival curves from prognosis of IPF between AE, no-AE RD and no-RD teams amongst sufferers with IPF. (B) Comparability of survival curves after hospitalization in sufferers with AE based on 2007 and 2016 definition of AE. AE acute exacerbation, RD respiratory deterioration, IPF idiopathic pulmonary fibrosis.
Within the unadjusted Cox regression evaluation, older age, decrease physique mass index (BMI), Charlson comorbidity index, FVC and DLco, shorter distance, and decrease SpO2 (resting and the bottom) throughout the 6MWT, DP, and AE had been considerably related to poor prognosis in sufferers with IPF (Desk 3). Following multivariable evaluation, AE was independently related to poor prognosis (HR, 1.740; 95% CI, 1.220–2.481, p = 0.002), together with older age, decrease BMI and FVC, DP, shorter distance and decrease the minimal SpO2 throughout 6MWT.
Comparability of incidences, and outcomes
When information of all sufferers had been re-analyzed based mostly on the previous definition of AE, it was famous that AE occurred in 64 (14.4%; 14 particular and 50 suspected) sufferers with IPF, and the 1-, 2- and 3-year cumulative incidences of AE had been 4.2%, 8.9%, and 12%, respectively. The in-hospital mortality charges of sufferers with AE had been 32.8%. Whereas a decrease P/F ratio was seen as an unbiased prognostic issue for in-hospital mortality in sufferers with AE (Desk S5), AE was an unbiased prognostic issue for total mortality in sufferers with IPF (HR, 2.978; 95% CI, 1.433–6.109, p = 0.003) (Desk S6).
The revised definition numerically elevated the general incidence of AE from 14.4 to 17.5% (relative enhance of 20.4%) in sufferers with IPF (Fig. 3); 14 sufferers, not categorised as AE however as no-AE RD by the previous definition, had been re-classified as triggered AE by the revised diagnostic standards. There was no suspected case of AE as per the revised definition. The revised definition additionally decreased in-hospital mortality after AE from 32.8 to 29.5% (relative lower of 10.1%) in sufferers with IPF; the 14 sufferers categorised as triggered AE by the revised standards, confirmed numerically decrease in-hospital mortality price (14.3% vs. 32.8%, p = 0.211) in contrast with these with idiopathic AE. Nevertheless, total mortality after hospitalization was related between sufferers who skilled AE by each the definitions (81.3% vs. 82.1%, Fig. 2B).

Change within the incidence of AE in sufferers with IPF based on 2007 and 2016 definition of AE. IPF idiopathic pulmonary fibrosis, AE acute exacerbation, RD respiratory deterioration.